Press Release

Extracorporeal Membrane Oxygenation Machine Market to Grow at 4.88% CAGR through 2029F

Increased prevalence of lifestyle diseases and availability of skilled professionals to operate ECMO machines is expected to drive the Global Extracorporeal Membrane Oxygenation Machine Market growth in the forecast period, 2025-2029.


According to TechSci Research report, “Extracorporeal Membrane Oxygenation Machine Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2029F”, the Global Extracorporeal Membrane Oxygenation Machine Market stood at USD 394.21 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.88% through 2029. The global Extracorporeal Membrane Oxygenation (ECMO) machine market is driven by several pivotal factors. One of the key drivers is the rising incidence of cardiovascular and respiratory diseases, which has created a higher demand for ECMO machines. The increased availability of technologically advanced ECMO machines has further fueled the market growth. These innovative machines offer improved functionality, efficiency, and patient outcomes. The growing number of ECMO centers across the globe has contributed to the expansion of the market. These centers provide specialized care and expertise in the field of ECMO, attracting more patients and driving the market forward. Overall, these factors collectively play a significant role in shaping the dynamics of the global ECMO machine market.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Extracorporeal Membrane Oxygenation Machine Market

The global market for Extracorporeal Membrane Oxygenation (ECMO) machines is experiencing significant growth driven by an increase in the incidence of cardiopulmonary diseases and respiratory failures. As the prevalence of these conditions continues to rise, the demand for life-saving ECMO devices is soaring. The growth in the market can be attributed to several factors. Technological advancements in ECMO procedures, such as the development of more efficient oxygenators and improved circuit designs, have contributed to the increased adoption of ECMO therapy. These advancements have enabled healthcare professionals to provide better care and support to patients in critical conditions.

The growing awareness among healthcare professionals about the benefits of ECMO and the higher survival rates observed among patients undergoing ECMO treatment have fueled the demand for these machines. The remarkable outcomes achieved through ECMO therapy have prompted healthcare providers to recognize the significance of incorporating this advanced technology into their treatment protocols.

The market for ECMO machines is influenced by the rise in government and private funding for better healthcare infrastructure. Governments around the world are increasingly recognizing the importance of investing in advanced medical technologies like ECMO to improve patient outcomes. This has led to the establishment of specialized ECMO centers and the procurement of ECMO machines in various healthcare facilities.

Ongoing research and development activities aimed at making ECMO machines more compact and efficient have played a crucial role in driving the market growth. Manufacturers are continuously striving to reduce the size and weight of ECMO devices while enhancing their functionality and ease of use. These advancements have not only made ECMO therapy more accessible but also improved patient comfort and outcomes.

The global market for ECMO machines is witnessing remarkable growth due to the rising incidence of cardiopulmonary diseases, technological advancements, increasing awareness, higher survival rates, funding for healthcare infrastructure, and ongoing research and development efforts. With its continuous evolution and innovation, ECMO is set to revolutionize the treatment of critical respiratory and cardiac conditions, providing a lifeline to patients in need. The future of ECMO looks promising as it continues to pave the way for improved patient care and outcomes.

 

The Global Extracorporeal Membrane Oxygenation Machine Market is segmented into component type, modality, patient type, application, regional distribution, and company.

Based on patient type, adults currently dominate in terms of usage and market demand. While ECMO can be utilized across all age groups, including neonates, pediatric, and adult patients, the adult segment exhibits the highest utilization due to several factors. Adults constitute a larger proportion of patients requiring ECMO support compared to neonates and pediatric patients. This is attributed to the higher prevalence of conditions such as acute respiratory distress syndrome (ARDS), cardiac failure, and severe respiratory failure among adults. These conditions often necessitate advanced life support measures like ECMO to maintain adequate oxygenation and circulation.

ECMO technology has witnessed significant advancements over the years, particularly in the development of ECMO circuits and devices tailored for adult patients. These advancements have resulted in improved safety, efficiency, and ease of use, making ECMO a viable treatment option for a wider range of adult patients with complex medical conditions. The rising incidence of severe respiratory illnesses, such as pneumonia, influenza, and acute respiratory distress syndrome (ARDS), among adults further drives the demand for ECMO support in this demographic. As the aging population continues to grow and the prevalence of chronic diseases increases, the need for ECMO therapy in adults is expected to rise correspondingly.

Based on region, several factors contribute to North America's dominance in the global Extracorporeal Membrane Oxygenation (ECMO) machine market. The region's advanced healthcare infrastructure facilitates the efficient adoption and utilization of ECMO technology. With high healthcare expenditure, North America invests extensively in cutting-edge medical devices and technologies. The presence of leading medical device manufacturers further enhances the region's dominance in the ECMO machine market, as these companies possess the expertise and resources to develop high-quality ECMO machines meeting healthcare providers' and patients' demands.

North America experiences a high incidence of cardiovascular and respiratory diseases, driving the demand for ECMO as a life-saving procedure. The population faces a significant burden of these diseases, necessitating the availability and accessibility of ECMO machines for critical care interventions. Robust research and development initiatives in ECMO technology strengthen North America's position in the market, fostering continuous advancements driven by collaborations among academia, healthcare institutions, and industry stakeholders. The government's support for technology integration in healthcare creates a favorable environment for the ECMO machine market's growth in North America. Policies and initiatives aimed at promoting advanced medical technologies, including ECMO, contribute to market expansion and facilitate improved patient outcomes. Overall, North America's comprehensive healthcare ecosystem, coupled with a high disease burden and supportive regulatory environment, sustains its leadership in the global ECMO machine market.

 

Major companies operating in Global Extracorporeal Membrane Oxygenation Machine Market are:

  • Medtronic plc
  • Sorin Group
  • Terumo Cardiovascular Systems Corporation
  • MAQUET Holding B.V. & Co. KG
  • Medos Medizintechnik AG
  • Nipro Medical Corporation
  • MicroPort Scientific Corporation
  • XENIOS AG
  • LivaNova PLC
  • EUROSETS S.r.l.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

The future of the Extracorporeal Membrane Oxygenation (ECMO) Machine Market holds significant promise, buoyed by a convergence of factors that are poised to drive its growth trajectory. Technological advancements stand at the forefront of this optimistic outlook, with continuous innovation enhancing the capabilities and efficiency of ECMO machines. These advancements not only improve the performance and reliability of ECMO systems but also contribute to enhanced patient outcomes and safety. The escalating incidence of cardiovascular and respiratory diseases globally is fueling the demand for advanced medical interventions such as ECMO. As these conditions continue to pose significant health challenges and strain healthcare systems, the need for effective treatment modalities like ECMO becomes increasingly pronounced. ECMO therapy offers a vital lifeline for patients with severe cardiac or pulmonary dysfunction, providing temporary support to vital organ systems while allowing for recovery or transplantation. The expanding adoption of ECMO in intensive care units (ICUs) across the globe is poised to drive market growth. As healthcare facilities strive to improve patient care and outcomes, ECMO has emerged as a valuable tool in the armamentarium of critical care medicine. The development of portable ECMO machines represents a significant milestone in the evolution of ECMO technology. These compact and transportable systems offer greater flexibility and accessibility, allowing for the provision of ECMO therapy in a wider range of clinical settings, including ambulances and remote healthcare facilities. This expansion of ECMO's reach is expected to further fuel market growth and broaden its applications beyond traditional hospital settings.,” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

Extracorporeal Membrane Oxygenation Machine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component Type (Pumps, Oxygenator, Controllers, Cannula, Accessories), By Modality (Veno-Arterial, Veno-Venous, Arterio-Venous), By Patient Type (Neonates, Pediatric, Adult), By Application (Respiratory, Cardiac, ECPR), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Extracorporeal Membrane Oxygenation Machine Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Extracorporeal Membrane Oxygenation Machine Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News